Insider Trading History of Lim Bryant David

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Lim Bryant David since 2018. This trader's CIK number is 1752888. At the time of last reporting, Lim Bryant David was the CLO, Interim CFO, Corp Sec. of Prelude Therapeutics Inc. (stock ticker symbol PRLD). Also see all insider trading activities at Prelude Therapeutics Inc.

Note that in the past Lim Bryant David also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Prelude Therapeutics Inc (PRLD) by Lim Bryant David

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 PRLD 25,000 $22,650 0 $0 0 $0
2023 PRLD 2,400 $12,936 0 $0 0 $0

Yearly summary of insider trading at Aceragen, Inc. (IDRA) by Lim Bryant David

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 IDRA 0 $0 10,806 $23,299 0 $0
2020 IDRA 0 $0 1,603 $2,853 0 $0
2018 IDRA 4,000 $12,200 0 $0 0 $0


Insider trading activities at 2 companies by Lim Bryant David:

1. Prelude Therapeutics Inc (PRLD)

2. Aceragen, Inc. (IDRA)

Table 1. Insider trading of Prelude Therapeutics Inc (PRLD) by Lim Bryant David

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-12-19 PRLD Buy 25,000 .91 22,650
2023-05-24 PRLD Buy 2,400 5.39 12,936

Table 2. Insider trading of Aceragen, Inc. (IDRA) by Lim Bryant David

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-03-25 IDRA Sale 7,630 1.36 10,376
2021-01-12 IDRA Sale 1,711 4.21 7,201
2021-01-05 IDRA Sale 1,465 3.91 5,722
2020-01-07 IDRA Sale 1,603 1.78 2,853
2018-12-21 IDRA Buy 4,000 3.05 12,200

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lim Bryant David (CLO, Interim CFO, Corp Sec. of Prelude Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.